cbdMD
YCBD
cbdMD (YCBD) earnings history
Most recent quarter
- Fiscal period
- Q3 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.11
- EPS estimate
- −$0.03
- EPS surprise
- −266.67%
- Revenue surprise
- −2.44%
- Revenue
- $5.5M
- Revenue estimate
- $5.7M
- Reported
- Aug 13, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2026 | Aug 13, 2026 | −$0.03 | −$0.11 | −266.67% | $5.5M | SEC |
| Q2 2026 | May 14, 2026 | −$0.05 | −$0.08 | −60.00% | $5.6M | SEC |
| Q1 2026 | Feb 17, 2026 | −$0.06 | −$0.04 | +33.33% | $5.0M | SEC |
| Q4 2025 | Dec 19, 2025 | −$0.07 | $2.78 | +4071.43% | $4.7M | SEC |
| Q3 2025 | Aug 14, 2025 | −$0.02 | −$0.21 | −950.00% | $4.6M | SEC |
| Q2 2025 | May 15, 2025 | −$1.60 | −$1.90 | −18.75% | $4.7M | SEC |
| Q1 2025 | Feb 13, 2025 | −$2.96 | −$1.76 | +40.54% | $5.1M | SEC |
| Q4 2024 | Dec 18, 2024 | −$3.60 | $0.00 | +100.00% | $4.6M | SEC |
| Q3 2024 | Aug 14, 2024 | −$4.96 | −$1.20 | +75.81% | $5.2M | SEC |
| Q2 2024 | May 15, 2024 | −$6.00 | −$10.80 | −80.00% | $4.4M | SEC |
| Q1 2024 | Feb 13, 2024 | −$5.92 | −$5.36 | +9.46% | $5.4M | SEC |
| Q4 2023 | Dec 22, 2023 | −$6.08 | −$46.96 | −672.37% | $5.7M | SEC |
| Q3 2023 | Aug 10, 2023 | −$21.60 | −$9.28 | +57.04% | $6.1M | SEC |
| Q2 2023 | May 15, 2023 | −$28.80 | −$13.92 | +51.67% | $6.2M | SEC |
| Q1 2023 | Feb 13, 2023 | −$126.00 | −$28.80 | +77.14% | $6.1M | SEC |
| Q1 2022 | Feb 10, 2022 | −$9.00 | −$126.00 | −1300.00% | $9.3M | — |
| Q4 2021 | Dec 17, 2021 | −$16.20 | −$25.20 | −55.56% | $9.8M | — |
| Q3 2021 | Aug 12, 2021 | −$14.40 | $7.20 | +150.00% | $10.6M | — |
| Q2 2021 | May 12, 2021 | −$10.80 | −$86.40 | −700.00% | $11.8M | — |
| Q1 2021 | Feb 9, 2021 | −$7.20 | −$64.80 | −800.00% | $12.3M | — |
Quarterly revenue
Frequently asked questions
When did cbdMD (YCBD) last report earnings?
cbdMD last reported on Aug 13, 2026, covering fiscal Q3 2026.
Did YCBD beat earnings estimates?
No. cbdMD reported EPS of −$0.11 for Q3 2026 against a −$0.03 estimate — a 266.67% miss.
How much revenue did YCBD report last quarter?
cbdMD reported $5.5M in revenue for Q3 2026, against a consensus estimate of $5.7M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.